Propofol-thiopentone admixture - Hypnotic dose, pain on injection and effect on blood pressure

Anaesthesia and Intensive Care

Volumn 27, Issue 4, 1999, Pages 346-356

  Jones, D ^a,b   Prankerd, R ^a   Lang, C ^a   Chilvers, M ^a,b   Bignell, S ^a,b   Short, T ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Anaesthetics, intravenous: thiopentone, propofol, pain, blood pressure

Indexed keywords

ANESTHETIC AGENT; LIDOCAINE; PROPOFOL; THIOPENTAL;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEMODYNAMICS; HUMAN; INJECTION PAIN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 0032842701     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x9902700403     Document Type: Article

References (33)

1. White PF. American Society of Anesthesiologists' Annual Refresher Course Lectures 1993; 121:1-7.
2. Chung F. Recovery pattern and home readiness after ambulatory surgery. Anesth Analg 1995; 80:896-902.
3. Uppington J, Kay NH, Sear JW. Propofol ("Diprivan") as a supplement to nitrous oxide-oxygen for the maintenance of anaesthesia. Postgrad Med 1985; 61 (suppl 3):80-83.
4. John RA, Harper NJN, Chadwick S, Vohra A. Pain on injection of propofol. Methods of alleviation. Anaesthesia 1990; 45:439-442.
5. Lee TW, Loewenthal AE, Strachan JA, Todd BD. Pain during injection of propofol - the effect of prior administration of thiopentone. Anaesthesia 1994; 49:817-818.
6. Peacock JE, Lewis RP, Reilly CS, Nimmo WS. Effect of different rates of infusion of propofol for induction of anaesthesia in elderly patients. Br J Anaesth 1990; 65:346-352.
7. Prankerd R, Jones RDM. The physicochemical compatibility of injectable propofol-thiopental sodium admixtures. Am Health System Pharm 1996; 53:2606-2610.
8. Naguib M, Sari-Kouzel A. Thiopentone-propofol hypnotic synergism in patients. Br J Anaesth 1991; 67:4-6.
9. Diprivan product information. Macclesfield, Cheshire, United Kingdom: ICI Pharmaceutical; 1993.
10. Pentothal product information. Kurnell, New South Wales, Australia: Abbott Australasia P/L; 1993.
11. Westhuyzen J, Cochrane AD, Tesar PJ, Mau T, Cross DB, Frenneauz MP. Effect of preoperative supplementation with α-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations. Thorac Cardiovasc Surgery 1997; 113:942-948.
12. Palmer TEA, Cumpston PHV, Jones RDM. MADAM: Multi-channel anaesthetic data acquisition machine. ANZCA ASM, Townsville; May 1995; 61.
13. Stanski DR, Burch PG, Harapat S, Richards RK. The pharmacokinetics and anaesthetic potency of a thiopental isomer. Pharm Sci 1983; 72:937-940.
14. Plummer GF. Improved method for the determination of propofol in blood by high performance liquid chromatography with fluorescence detection. Chromatograph 1987; 421:171-176.
15. Plummer JL. Design and analysis of drug combination experiments. Pain Reviews 1998, 5:16-31.
16. Van Hemelrijck J, Gonzales JM, White PF. Pharmacology of intravenous anesthetic agents. In: Rogers MC, Tinker JH, Covino BG, Longnecker DE, eds. Principles and Practice of Anesthesiology. Chicago; IL Mosby Year Book, 1993; 1131-1154.
17. Plummer JL, Short TG. Analysis of effects of drug combinations. Br Anaesth 1992; 68:114.
18. Seltzer JL, Gerson JI, Allen FB. Comparison of the cardiovascular effects of bolus vs incremental administration of thiopentone. Br J Anaesth 1980; 52:527-529.
19. Whittington MA, Jefferys JG, Traub RD. Effects of intravenous anaesthetic agents on fast inhibitory oscillations in the rat hippocampus in vitro. Br Pharm 1996; 118:1977-1986.
20. Hara M, Kai Y, Ikemoto Y. Enhancement by propofol of the gamma-aminobutyric acidA response in dissociated hippocampal pyramidal neurones of the rat. Anesthesiology 1994; 81: 988-994.
21. Peacock JE, Blackburn A, Sherry KM, Reilly CS. Arterial and jugular bulb blood propofol concentrations during induction of anaesthesia. Anesth Analg 1995; 80:1002-1006.
22. Leslie K, Crankshaw DP. Lean tissue mass is a useful predictor of induction dose requirements of propofol. Anaesth Intensive Care 1991; 19:57-60.
23. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997; 86: 10-23.
24. Ben-Shlomo I, Tverskoy M, Fleyshman G, Cherniavsky G. Hypnotic effect of IV propofol is enhanced by i.m. administration of either lignocaine or bupivacaine. Br J Anaesth 1997: 78: 375-377.
25. Himes RS, DiFazio CH, Burney RG. Effects of lidocaine on the anesthetic requirements for nitrous oxide and halothane. Anesthesiology 1977; 47:437-440.
26. Johnson RA, Harper NJN, Chadwick S, Vohra A. Pain on injection of propofol. Methods of alleviation. Anaesthesia 1990; 45: 439-442.
27. Klemenl W, Arndt JO. Pain on injection of propofol. Effects of concentration and diluent. Br J Anaesth 1991; 67:281-284.
28. Eriksson M, Englesson S, Niklasson F, Hartvig P. Effect of lignocaine and pH on propofol-induced pain. Br J Anaesth 1997; 78:502-506.
29. Gauss A, Heinrich, Wilder-Smith OHG. Echocardiographic assessment of the haemodynamic effects of propofol: a comparison with etomidate and thiopentone. Anaesthesia 1991; 46: 99-105.
30. Seavell CR, Cook TM, Cox CM. Topical lignocaine and thiopentone for the insertion of a laryngeal mask airway. A comparison with propofol. Anaesthesia 1996; 51:699-701.
31. Rolly G, Versichelen L. Comparison of propofol and thiopentone for induction of anaesthesia in premedicated patients. Anaesthesia 1985; 40:945-948.
32. Brussel T, Theissen JL, Vigfusson G, Lunkenheimer PP, Van Aken H, Lawin P. Hemodynamic and cardiodynamic effects of propofol and etomidate: negative inotropic properties of propofol. Anesth Analg 1989; 69:35-40.
33. Stokes DN, Hutton P. Rate-dependent induction phenomena with propofol: implications for the relative potency of intravenous anesthetics. Anesth Analg 1991; 72:578-583.